• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同实验条件下心脏组织和灌注液中的纤溶酶原激活剂含量。

Plasminogen activator content in heart tissue and perfusate under various experimental conditions.

作者信息

Lyutova L V, Andreenko G V, Perova E V, Malchikova L S

出版信息

Cor Vasa. 1983;25(3):206-12.

PMID:6684535
Abstract

In order to elucidate the mechanisms of plasminogen activator release into the circulation during the first minutes of experimental myocardial ischaemia in vitro, isolated rat hearts were perfused under optimal conditions and under conditions inducing myocardial ischaemia. In ventricular tissues the content of plasminogen a activator was measured; in the perfusate the plasminogen activator and anticoagulating activities were determined. Under optimal conditions the plasminogen activator content in contracting heart was found to be essentially the same as under in vivo conditions; in the perfusates the release of plasminogen activator and of substances possessing the anticoagulating activity was insignificant. Under myocardial ischaemia the release of these substances into the circulation increased, while plasminogen activator content decreased.

摘要

为了阐明在体外实验性心肌缺血的最初几分钟内纤溶酶原激活物释放到循环中的机制,在最佳条件下以及在诱导心肌缺血的条件下对离体大鼠心脏进行灌注。测定心室组织中纤溶酶原激活物的含量;测定灌注液中纤溶酶原激活物和抗凝活性。在最佳条件下,发现收缩期心脏中的纤溶酶原激活物含量与体内条件下基本相同;在灌注液中,纤溶酶原激活物和具有抗凝活性的物质的释放量微不足道。在心肌缺血时,这些物质向循环中的释放增加,而纤溶酶原激活物含量降低。

相似文献

1
Plasminogen activator content in heart tissue and perfusate under various experimental conditions.不同实验条件下心脏组织和灌注液中的纤溶酶原激活剂含量。
Cor Vasa. 1983;25(3):206-12.
2
[A histochemical study of the distribution of plasminogen activator in myocardial tissue in experimental ischemia].[实验性缺血心肌组织中纤溶酶原激活物分布的组织化学研究]
Biull Eksp Biol Med. 1976 Feb;81(2):A61-3.
3
[The heparin--tissue plasminogen activator complex and some of its properties].[肝素-组织型纤溶酶原激活物复合物及其某些特性]
Biokhimiia. 1983 Oct;48(10):1687-90.
4
Local heat shock priming promotes recanalization of thromboembolized microvasculature by upregulation of plasminogen activators.
Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1632-9. doi: 10.1161/01.ATV.0000223144.65958.c3. Epub 2006 Apr 20.
5
Changes in plasminogen activator activity and plasmin inhibition in the pig during experimental hypovolaemia.实验性低血容量期间猪体内纤溶酶原激活物活性和纤溶酶抑制作用的变化
Thromb Haemost. 1985 Feb 18;53(1):130-3.
6
[Experimental studies of the liberation of plasminogen activator by DDAVP].
Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(4):567-74.
7
Secretion of cardiac plasminogen activator during hypoxia-induced right ventricular hypertrophy.缺氧诱导右心室肥厚过程中心脏纤溶酶原激活物的分泌
J Mol Cell Cardiol. 1997 Nov;29(11):3105-14. doi: 10.1006/jmcc.1997.0536.
8
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.急性缺血性心脏病患者的纤维蛋白溶解。特别提及组织型纤溶酶原激活剂治疗对纤维蛋白溶解、凝血和补体途径的全身影响。
Dan Med Bull. 1993 Sep;40(4):383-408.
9
Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.体外循环期间心包形态和纤溶活性的变化。
J Thorac Cardiovasc Surg. 1993 Aug;106(2):339-45.
10
The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat.在大鼠心肌梗死3个月后,与存活心肌相比,瘢痕中的纤溶酶原-MMP系统激活程度更高。
J Mol Cell Cardiol. 2005 Jan;38(1):193-204. doi: 10.1016/j.yjmcc.2004.10.017. Epub 2004 Dec 9.